See also this year's filing and all EDGAR filings for this company.
PDF Report 0001479290_2021_Revance_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001479290, Revance Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 450,003,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 218,307,000 |
| 2 | PropertyPlantAndEquipmentNet | 17,499,000 |
| 3 | remainder_Assets | 34,411,000 |
| 4 | LiabilitiesCurrent | 60,964,000 |
| 5 | LiabilitiesNoncurrent | 104,440,000 |
| 6 | remainder_Liabilities | 180,526,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 599,185,061 |
| 9 | ResearchAndDevelopmentExpense | 151,037,584 |
| 10 | remainder_Expenses | 6,774,871 |
| 11 | remainder_Revenues | 433,150 |
| 12 | remainder_NetIncome | 3,626,107 |
| 13 | remainder_ComprehensiveNetIncome | 1,199 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 720,220,000 |
| 1 | Liabilities | 345,930,000 |
| 2 | Expenses | 756,997,516 |
| 3 | Revenues | 433,150 |
| 4 | StockholdersEquity | 374,290,000 |
| 5 | NetIncome | -752,938,259 |
| 6 | ComprehensiveNetIncome | -752,937,660 |
| 7 | BaseVar | 913,603,986 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.118 |
| 9 | EconomicCapitalRatio | 1.53 |
Edgar->Model Mapping
Feature Distribution
Change over Time
